Food can affect a cell in the same way hormones do
VIB researchers connected to the Katholieke Universiteit Leuven have discovered an important new mechanism with which cells can detect nutrients. This happens in the same way - and with the same effects – as when cells receive a message from a hormone. This finding can teach us more about how food affects our body; and, furthermore, it can form the basis for new candidate targets for medicines.
In addition to receptors, cells also have transport proteins that can carry nutrients through the cell membrane to the inside of the cell, where they can be put to use. Furthermore so-called ‘transceptors’ have been discovered that sense and transport food simultaneously. Now, VIB researcher Griet Van Zeebroeck and her colleagues in Johan Thevelein’s group have shown for the first time how one of these transceptors (called Gap1) works. Gap1 transports amino acids (a protein’s building blocks) to the inside of a cell. At the same time, via the same mechanisms that cells use to transmit signals from hormones, Gap1 sends the cell a signal that food is present. The transceptor apparently uses the same binding site to recognize the food as it uses to grasp the food for transport.
This research has been conducted on yeast cells, as yeast (Saccharomyces cerevisiae) is a micro-organism that is used as a model organism. Yeast cells are surprisingly similar to human cells, but they are easier to cultivate and manipulate. Very often, proteins that are found in yeast - transport proteins and receptors, for example - have similar variants in human cells.
This research can have important implications for the development of medicines. About half of all medicines are transmitted to cells via receptors, because receptors are located on the cells’ exterior surface and are therefore the best targets for medicines. If these newly discovered transceptors are also found in humans, then an unexpected new group of candidate targets for medicines becomes available - offering promising possibilities for the treatment of metabolic diseases.

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.